Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-06

FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals LLC's supplemental application for montelukast sodium (generic montelukast).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST)